EAT: A Reliable Eating Assessment Technology for Free-living Individuals
NCT ID: NCT06118528
Last Updated: 2024-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
72 participants
INTERVENTIONAL
2024-09-04
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior
NCT06547320
GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss
NCT03254953
mHealth Messages to Sustain Recent Weight Loss - Phase 2
NCT02279017
Improving Self-Monitoring in Weight Loss With Technology
NCT00277771
Investigating the Impact of Self-monitoring Feedback for Health Behaviors
NCT03940599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blur Obfuscation
Blur Obfuscation
Blurring is applied to the RGB images.
Edge Obfuscation
Edge Obfuscation
A black background and simple outlines of objects/people are applied to the RGB images.
Cartoon Obfuscation
Cartoon Obfuscation
Cartoonization is applied to the RGB images.
No Obfuscation (Raw)
No Obfuscation (raw)
No editing is performed on the RGB images.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blur Obfuscation
Blurring is applied to the RGB images.
Cartoon Obfuscation
Cartoonization is applied to the RGB images.
Edge Obfuscation
A black background and simple outlines of objects/people are applied to the RGB images.
No Obfuscation (raw)
No editing is performed on the RGB images.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chicago metropolitan area resident
* Able to speak, read and write in English
* Has a valid phone number
* Owns a smartphone
* Has access to a computer
Exclusion Criteria
* Experienced significant weight loss/gain in the last three months (25 lbs or more)
* Diagnosed with or has a family history of genetic obesity syndromes (e.g., Prader-Willi, Bardet-Biedl, Cohen Syndrome)
* Member of household enrolled in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nabil Alshurafa, PhD
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00215714
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.